Key takeaways
New guidance has moved away from automatically stopping tirzepatide (Mounjaro, Zepbound) seven days before surgery. Instead, whether you should pause the medication depends on your individual risk of delayed stomach emptying.
Tirzepatide does not directly interact with anesthesia. The concern is that it can slow digestion, increasing the risk of food remaining in the stomach during surgery.
Don't stop Mounjaro or Zepbound on your own before a procedure. Your surgeon, anesthesiologist, and healthcare provider can help decide the safest plan.
Here's what we'll cover
Here's what we'll cover
Here's what we'll cover
Key takeaways
New guidance has moved away from automatically stopping tirzepatide (Mounjaro, Zepbound) seven days before surgery. Instead, whether you should pause the medication depends on your individual risk of delayed stomach emptying.
Tirzepatide does not directly interact with anesthesia. The concern is that it can slow digestion, increasing the risk of food remaining in the stomach during surgery.
Don't stop Mounjaro or Zepbound on your own before a procedure. Your surgeon, anesthesiologist, and healthcare provider can help decide the safest plan.
If you're wondering if you need to stop tirzepatide before surgery, the answer is likely no, but it depends on your healthcare team’s specific recommendations. While many people taking Mounjaro or Zepbound were once told to stop the medication a week before surgery, experts currently recommend a more personalized approach based on your individual risk rather than a blanket rule.
The reason has less to do with tirzepatide and anesthesia itself and more to do with how the medication affects your stomach. Because tirzepatide slows stomach emptying, some people may still have food in their stomach when it’s time for anesthesia. This can increase the risk of complications.
But that doesn't mean everyone needs to stop taking it before a procedure. Here's what the latest guidance says about when to stop tirzepatide before surgery, who may need to take extra precautions, and when it's generally safe to restart your medication afterward.
When to stop tirzepatide before surgery
The short answer: It depends. And in many cases, you may not need to stop tirzepatide at all before surgery. Previous guidance recommended considering stopping GLP-1 medications such as tirzepatide at least one week before surgery. But more recent guidance advises a more individualized, risk-based approach. That means the decision should consider your symptoms, overall health, where you are in treatment, and the type of procedure you're having — not just the medication itself.
For many people, that means they may be able to continue taking tirzepatide before elective surgery. According to the updated guidance, most patients at low risk for delayed stomach emptying can stay on their medication, while those at higher risk may need additional precautions or, in some cases, temporarily stop treatment.
You may be considered at higher risk if you:
Recently started tirzepatide or are still increasing your dose (the dose-escalation phase)
Have ongoing nausea, vomiting, abdominal pain, bloating, or constipation
Are taking a higher dose and experiencing significant gastrointestinal side effects
Have another condition that slows stomach emptying, such as Parkinson's disease
If you fall into one of these higher-risk groups, stopping tirzepatide isn't the only option.
Depending on your situation, your surgical team may recommend following a liquid-only diet for 24 hours before surgery, adjusting your anesthesia plan, delaying an elective procedure until your symptoms improve, or using a point-of-care gastric ultrasound to help determine whether your stomach has emptied.
The move toward a more personalized approach reflects the reality that there isn't a one-size-fits-all answer.
Pausing tirzepatide use may reduce concerns about delayed stomach emptying, but it can also disrupt blood sugar management in people with diabetes or interrupt treatment for obesity. Your care team will weigh those tradeoffs when deciding what's safest for you.
If you're having emergency surgery, there usually isn't time to adjust your medication schedule. In those situations, anesthesiologists generally assume your stomach may not be empty and use techniques that help lower the risk of aspiration during anesthesia.
The bottom line: Let your surgeon, anesthesiologist, and the healthcare provider who prescribes your tirzepatide know you're taking the medication as soon as your procedure is scheduled. Together, they can determine whether you should continue taking it, pause it temporarily, or simply take additional precautions before surgery.
Why stop tirzepatide before anesthesia and surgery?
The main reason your healthcare team may recommend temporarily stopping tirzepatide before surgery is that it can leave food in your stomach longer than expected. If your stomach isn't completely empty when you receive anesthesia, there's a small chance that food or liquid could come back up and enter your lungs—a serious complication called pulmonary aspiration.
That's why you're typically asked to stop eating and drinking for several hours before surgery. Tirzepatide delays how quickly the stomach empties, so some people may still have food in their stomach despite following the usual fasting instructions. This effect also helps explain why the medication makes you feel fuller for longer and eat less.
Researchers have found that people taking GLP-1 medications are more likely to have residual stomach contents before procedures than those who aren't taking these medications.
However, evidence that this translates into more aspiration events is limited, and large studies have not found an increased risk of postoperative aspiration pneumonia. That's one reason recent guidance has shifted away from stopping these medications for everyone before surgery and toward assessing each person's individual risk.
Your care team may be more cautious if you're early in treatment, recently increased your dose, or have ongoing digestive symptoms such as nausea, vomiting, bloating, or abdominal pain, since these are all signs that stomach emptying may be slower than usual.
The good news is that aspiration during elective surgery is rare, and anesthesiologists have several ways to reduce the risk when they know you're taking tirzepatide.
Tirzepatide and anesthesia
Tirzepatide isn't thought to change how anesthesia medications work. Instead, the concern is that it may leave food in the stomach longer than expected, increasing the risk of aspiration during anesthesia.
That doesn't mean you'll automatically need to stop taking tirzepatide before surgery. Instead, your anesthesiologist will consider several factors when deciding how to proceed, including:
Whether you're currently taking tirzepatide, or if you have stopped it recently
How long you've been on the medication and whether you're still increasing your dose
Whether you've recently had nausea, vomiting, bloating, abdominal pain, or constipation
The type of procedure you're having and whether it requires general anesthesia, deep sedation, or local anesthesia
Whether you have other medical conditions that can slow stomach emptying
Based on those factors, your care team may recommend one or more strategies to help lower your risk during surgery, including:
Possible precaution | Why it may be recommended |
Following a liquid-only diet for 24 hours before surgery | May help reduce the amount of food remaining in the stomach |
Point-of-care gastric ultrasound | Can help determine whether the stomach appears empty before anesthesia |
Adjusting the anesthesia plan | May help protect your airway if aspiration is a concern |
Delaying an elective procedure | May be appropriate if you're experiencing significant gastrointestinal symptoms or are early in dose escalation |
Not every procedure carries the same level of concern. The risk is greatest for surgeries requiring general anesthesia or deep sedation, since these medications suppress the body's normal protective airway reflexes.
Procedures performed under local anesthesia alone may involve different considerations, but you should still let your healthcare team know you're taking tirzepatide well before your appointment.
Ultimately, the best thing to do is tell your surgeon, anesthesiologist, and the healthcare provider who prescribes your tirzepatide about all the medications you're taking before any surgery or procedure.
Tirzepatide before surgery: timing and guidance by procedure
There's no one-size-fits-all timeline for stopping tirzepatide before surgery. In fact, many people may not need to stop it at all before surgery. Instead, your care team will consider your individual risk of delayed stomach emptying, the type of procedure you're having, and the kind of anesthesia you'll receive.
Some of the factors they'll consider include:
Where you are in treatment: People who recently started tirzepatide or are still increasing their dose (the dose-escalation phase) are more likely to experience delayed stomach emptying and digestive side effects.
Whether you're having digestive symptoms: Ongoing nausea, vomiting, bloating, abdominal pain, or constipation may be a sign that your stomach is emptying more slowly than usual.
Your tirzepatide dose: Higher doses may be more likely to cause gastrointestinal side effects, particularly while your body is still adjusting to the medication.
The type of procedure you're having: Surgeries performed under general anesthesia or deep sedation typically require more careful planning than procedures done with local anesthesia alone.
Other medical conditions: Conditions that already slow stomach emptying, such as Parkinson's disease, may increase your risk of having food remain in your stomach before surgery.
If you're instructed to stop tirzepatide before surgery, ask exactly when to take your last dose and when you can safely restart it afterward. Don't skip doses or change your schedule without guidance from your healthcare team.
Fasting instructions still matter, especially if you're taking tirzepatide. Continue following the eating and drinking instructions your surgical team gives you. Standard fasting guidelines remain an important part of reducing the risk of aspiration before anesthesia.
When can you restart tirzepatide after surgery?
If your healthcare team had you stop tirzepatide before surgery, you can likely restart tirzepatide after surgery once you resume your usual diet. The exact timing depends on the type of surgery you had, how you're healing, and your healthcare team's recommendations.
If you had a minor outpatient procedure and are tolerating food and fluids normally, you may be able to restart tirzepatide relatively soon. More extensive surgeries or procedures followed by ongoing nausea, vomiting, or a restricted diet may require you to wait longer.
It's important not to restart tirzepatide too soon if you're still struggling to keep food or liquids down. Because the medication can cause nausea and slow stomach emptying, restarting it before your digestive system has recovered could make those symptoms worse or make it harder to stay hydrated and get adequate nutrition while you're healing.
If you had to stop tirzepatide for more than a few days, ask the healthcare provider who prescribes your tirzepatide whether you should resume your previous dose or restart at a lower one. Depending on how much time has passed, they may recommend gradually increasing your dose again to minimize gastrointestinal side effects.
If you're taking Mounjaro to manage type 2 diabetes, don't wait until after surgery to make a plan. Ask your healthcare team ahead of time when to stop Mounjaro before surgery, how your blood sugar will be managed while you're off the medication, and when it's safe to restart it afterward.
Bottom line
The guidance on tirzepatide before surgery has evolved from a one-size-fits-all model to a more individualized approach. Here’s what to know:
There's no universal timeline for if or when to stop tirzepatide before surgery. The right approach depends on your symptoms, where you are in treatment, and your procedure.
While tirzepatide doesn’t interact directly with anesthesia, it can delay stomach emptying and increase the risk of aspiration during anesthesia.
If you're early in treatment or have digestive symptoms like nausea or vomiting, your care team may recommend temporarily stopping tirzepatide or taking additional precautions.
Many people can continue taking tirzepatide before elective surgery, but that decision should be made with your healthcare providers.
Don't stop or restart tirzepatide on your own. Your healthcare team can tell you when to take your last dose before surgery and when it's safe to resume treatment afterward.
Frequently asked questions (FAQs)
Does tirzepatide interact with anesthesia?
Not directly. Tirzepatide isn't known to change how anesthesia medications work or cause a harmful reaction when the two are combined.
The concern with tirzepatide and surgery is that it can delay stomach emptying, meaning some people may still have food in their stomach despite fasting. During general anesthesia or deep sedation, that can increase the risk of food or liquid entering the lungs.
Your anesthesiologist will consider factors like your digestive symptoms, how long you've been taking tirzepatide, and the type of procedure you're having to determine the safest plan.
How long should you be off a GLP-1 before surgery?
There isn't a universal timeline anymore. In fact, most people may not need to stop a GLP-1 at all before surgery. Earlier guidance recommended stopping weekly GLP-1 medications like tirzepatide at least a week before surgery, but more recent recommendations favor a personalized approach that typically includes continuing GLP-1 drugs before and after surgery.
Can you have surgery if you are taking tirzepatide?
Yes. Many people taking tirzepatide can safely undergo surgery. Before your procedure, tell your surgeon and anesthesiologist that you're taking the medication. They can decide whether it’s safe to continue Zepbound or Mounjaro and anesthesia, or whether you should make temporary adjustments based on your individual risk.
Can you have surgery while taking Zepbound?
Yes. That said, if or when to stop taking Zepbound before surgery depends on factors like your digestive symptoms, where you are in treatment, and the type of anesthesia you'll receive. Your healthcare team will help determine the safest approach regarding Zepbound and anesthesia.
How long after surgery can I restart tirzepatide?
It depends on your recovery and the type of surgery you had. In general, your healthcare provider may recommend restarting tirzepatide once you're eating and drinking normally without significant nausea or vomiting.
DISCLAIMER
If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.
Mounjaro Important Safety Information: Read more about serious warnings and safety info.
Zepbound Important Safety Information: Read more about serious warnings and safety info.
GLP-1 Important Safety Information: Read more about serious warnings and safety info.
References
Brennan, M., Han, S. H., Ockerman, K., et al (2025). Perioperative Practice Patterns of Anaesthesiologists Surrounding Glucagon-Like Peptide-1 (GLP-1) Agonist Medications. Turkish Journal of Anaesthesiology and Reanimation, 53(2), 42–52. doi: 10.4274/TJAR.2025.241653. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC11931257/
Chen, Y. H., Zink, T., Chen, Y. W., et al. (2025). Postoperative Aspiration Pneumonia Among Adults Using GLP-1 Receptor Agonists. JAMA Network Open, 8(3), e250081. doi: 10.1001/jamanetworkopen.2025.0081. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC11880946/
El-Boghdadly, K., Dhesi, J., Fabb, P., et al. (2025). Elective peri-operative management of adults taking glucagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic peptide agonists and sodium-glucose cotransporter-2 inhibitors: a multidisciplinary consensus statement: A consensus statement from the Association of Anaesthetists, Association of British Clinical Diabetologists, British Obesity and Metabolic Surgery Society, Centre for Perioperative Care, Joint British Diabetes Societies for Inpatient Care, Royal College of Anaesthetists, Society for Obesity and Bariatric Anaesthesia and UK Clinical Pharmacy Association. Anaesthesia, 80(4), 412–424. doi: 10.1111/anae.16541. Retrieved from https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/10.1111/anae.16541
Farzam, K. & Patel, P. (2024). Tirzepatide. StatPearls. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK585056/
Holder, E. K., Ni, A., Levi, D., & International Pain and Spine Intervention Society's Patient Safety Committee. (2026). GLP-1 receptor agonists and conscious sedation. Interventional Pain Medicine, 5(1), 100734. doi: 10.1016/j.inpm.2025.100734. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC12828509/
Joshi, G. P., Abdelmalak, B. B., Weigel, W. A., et al. (2023). American Society of Anesthesiologists Consensus-Based Guidance on Preoperative Management of Patients (Adults and Children) on Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists. Retrieved from https://www.asahq.org/about-asa/newsroom/news-releases/2023/06/american-society-of-anesthesiologists-consensus-based-guidance-on-preoperative
Mehta, J., Tai, B., & Frunzi, J. (2026). Acute Systemic Complications Following High-Dose Semaglutide Reinitiation in an Elderly Patient. Clinical Case Reports, 14(5), e72356. doi: 10.1002/ccr3.72356. Retrieved from https://pubmed.ncbi.nlm.nih.gov/42038657/
Oprea, A. D., Ostapenko, L. J., Sweitzer, B., et al. (2025). Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement. British Journal of Anaesthesia, 135(1), 48–78. doi: 10.1016/j.bja.2025.04.001. Retrieved from https://www.bjanaesthesia.org/article/S0007-0912%2825%2900214-4/fulltext
Rüggeberg, A., Meybohm, P., & Nickel, E. A. (2024). Preoperative fasting and the risk of pulmonary aspiration-a narrative review of historical concepts, physiological effects, and new perspectives. BJA Open, 10, 100282. doi: 10.1016/j.bjao.2024.100282. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC11089317/
Sen, S., Potnuru, P. P., Hernandez, N., et al. (2024). Glucagon-Like Peptide-1 Receptor Agonist Use and Residual Gastric Content Before Anesthesia. JAMA Surgery, 159(6), 660–667. doi: 10.1001/jamasurg.2024.0111. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC10918573/
Sidik, A. I., Faybushevich, A. G., Hossain, M. L., et al. (2024). Enhancing Compliance With Preoperative Fasting Guidelines: A Closed-Loop Quality Improvement Initiative to Optimize Patient Safety and Outcomes. Cureus, 16(12), e75250. doi: 10.7759/cureus.75250. Retrieved from https://pubmed.ncbi.nlm.nih.gov/39764344/
Soliman, H., Coffin, B., & Gourcerol, G. (2021). Gastroparesis in Parkinson Disease: Pathophysiology, and Clinical Management. Brain Sciences, 11(7), 831. doi: 10.3390/brainsci11070831. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC8301889/














